IRTC · XBRL financial data

iRhythm Holdings financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (IRTC's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	265	323	411	493	592	747
Cost of revenue	70	109	129	161	184	220
Gross profit	195	214	282	332	408	527
Research and development	41	39	47	60	—	—
Selling, general and administrative	197	275	322	386	419	493
Total operating expenses	239	314	395	457	523	585
Operating income (loss)	(44)	(100)	(114)	(125)	(116)	(57)
Interest income	—	—	2	6	22	22
Interest expense	2	1	4	4	13	13
Other income (expense)	2	0	2	6	1	5
Income tax expense (benefit)	0	0	0	1	1	1
Net income (loss)	(44)	(101)	(116)	(123)	(113)	(45)
Earnings per share, basic USD per share	(1.58)	(3.46)	(3.88)	(4.04)	(3.63)	(1.39)
Earnings per share, diluted USD per share	(1.58)	(3.46)	(3.88)	(4.04)	(3.63)	(1.39)
Weighted average shares, basic millions of shares	28	29	30	31	31	32
Weighted average shares, diluted millions of shares	28	29	30	31	31	32

Fiscal years (IRTC's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	89	128	79	36	420	236
Marketable securities	247	112	134	98	116	348
Marketable securities, non-current	0	0	—	—	—	—
Accounts receivable	30	46	50	61	80	76
Inventory	5	10	15	14	14	22
Prepaid and other current assets	7	10	11	22	16	22
Total current assets	378	306	289	231	646	703
Property and equipment, net	34	56	76	104	125	152
Right-of-use asset	85	85	61	49	48	42
Goodwill	1	1	1	1	1	1
Total assets	512	463	448	433	931	1,020
Accounts payable	4	11	8	6	7	2
Accrued liabilities	41	51	65	83	85	129
Total current liabilities	66	88	89	107	111	152
Long-term debt	21	10	35	35	—	—
Lease liability, non-current	81	85	83	80	75	65
Total liabilities	170	183	208	223	841	867
Accumulated deficit	(305)	(406)	(522)	(646)	(759)	(803)
Total stockholders' equity	342	280	240	210	91	153
Total liabilities and equity	512	463	448	433	931	1,020
Common shares outstanding (cover page) millions of shares	29	30	30	31	31	32

Fiscal years (IRTC's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(44)	(101)	(116)	(123)	(113)	(45)
Stock-based compensation	42	55	58	77	76	88
Depreciation and amortization	7	10	13	16	21	21
Net cash from operating activities	(14)	(38)	(23)	(50)	3	81
Purchases of property and equipment	14	28	30	40	34	46
Net cash from investing activities	(132)	105	(52)	(1)	(123)	(277)
Share repurchases	—	—	0	0	25	0
Proceeds from long-term debt	0	—	—	—	—	—
Repayments of long-term debt	2	12	21	0	—	—
Net cash from financing activities	214	(29)	27	9	511	13
Net change in cash	68	39	(49)	(43)	392	(184)

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
iRhythm Holdings	247	224	51*	33.0M	Q2 FY26 10-QJun 30, 2026
Merit Medical Systems	504	416	65*	59.9M	Q3 FY26 10-QSep 30, 2026
TransMedics Group	491	190	17*	34.7M	Q2 FY26 10-QJun 30, 2026
Integer Holdings	14	450	37*	34.0M	Q3 FY26 10-QOct 2, 2026
GLAUKOS	162	211	39*	59.2M	Q3 FY26 10-QSep 30, 2026
Masimo	125	404	45	52.4M	Q1 FY26 10-QApr 4, 2026
Inspire Medical Systems	191	207	46*	29.0M	Q3 FY26 10-QSep 30, 2026
MSA Safety	187	536	82*	38.5M	Q3 FY26 10-QSep 30, 2026
Globus Medical	508	790	210*	134.3M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.